H-SER-LEU-LEU-LYS-NH2
|
|
|
- CAS号:
- 464924-27-4
- 英文名:
- H-SER-LEU-LEU-LYS-NH2
- 英文别名:
- SLLK;SLLK-NH2;H-SER-LEU-LEU-LYS-NH2;L-Seryl-L-leucyl-L-leucyl-L-lysine;L-Lysine, L-seryl-L-leucyl-L-leucyl-;SLLK, Control Peptide for TSP1 Inhibitor
- 中文名:
- H-SER-LEU-LEU-LYS-NH2
- 中文别名:
- SLLK,TSP1抑制剂控制肽;对照肽H-SER-LEU-LEU-LYS-NH2
- CBNumber:
- CB9724853
- 分子式:
- C21H41N5O6
- 分子量:
- 459.58
- MOL File:
- Mol file
|
|
|
H-SER-LEU-LEU-LYS-NH2化学性质
-
沸点:
-
815.4±65.0 °C(Predicted)
-
|
-
密度:
-
1.164±0.06 g/cm3(Predicted)
-
|
-
储存条件:
-
-15°C
-
|
-
酸度系数(pKa):
-
3.31±0.10(Predicted)
-
|
H-SER-LEU-LEU-LYS-NH2性质、用途与生产工艺
SLLK, Control Peptide for TSP1 Inhibitor 是 LSKL 的对照肽。
TGF-β1 is significantly lower (0.10±0.01 pg/mL) in the plasma of mice receiving LSKL compared with that in plasma of mice receiving SLLK control peptide at day 42 (0.20±0.02 pg/mL; P=0.0001). mRNA expression is assessed in the suprarenal aortic lysates obtained from mice receiving SLLK and LSKL peptides. Akita mice treated with 30 mg/kg LSKL have significantly increased nephrin expression, greater than twofold, compared with renal lysates from either saline controls or SLLK-treated mice.
H-SER-LEU-LEU-LYS-NH2
上下游产品信息
上游原料
下游产品
H-SER-LEU-LEU-LYS-NH2
生产厂家
464924-27-4, H-SER-LEU-LEU-LYS-NH2 相关搜索:
- peptide
- 目录多肽
- 标准品
- 多肽
- 对照肽H-SER-LEU-LEU-LYS-NH2
- SLLK,TSP1抑制剂控制肽
- 464924-27-4
- L-Seryl-L-leucyl-L-leucyl-L-lysine
- L-Lysine, L-seryl-L-leucyl-L-leucyl-
- SLLK-NH2
- SLLK
- SLLK, Control Peptide for TSP1 Inhibitor
- H-SER-LEU-LEU-LYS-NH2